- Home
- SSY vs TCBP Comparison
SSY vs TCBP Comparison
Compare SSY & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- TCBP
- Stock Information
- Founded
- SSY 1959
- TCBP 2013
- Country
- SSY United States
- TCBP United Kingdom
- Employees
- SSY N/A
- TCBP N/A
- Industry
- SSY Hospital/Nursing Management
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSY Health Care
- TCBP Health Care
- Exchange
- SSY Nasdaq
- TCBP Nasdaq
- Market Cap
- SSY 5.5M
- TCBP 5.0M
- IPO Year
- SSY N/A
- TCBP 2022
- Fundamental
- Price
- SSY $0.85
- TCBP $0.38
- Analyst Decision
- SSY
- TCBP Strong Buy
- Analyst Count
- SSY 0
- TCBP 1
- Target Price
- SSY N/A
- TCBP $2.40
- AVG Volume (30 Days)
- SSY 991.4K
- TCBP 3.1M
- Earning Date
- SSY 02-11-2025
- TCBP 11-25-2024
- Dividend Yield
- SSY N/A
- TCBP N/A
- EPS Growth
- SSY N/A
- TCBP N/A
- EPS
- SSY N/A
- TCBP N/A
- Revenue
- SSY $31,808,000.00
- TCBP N/A
- Revenue This Year
- SSY N/A
- TCBP N/A
- Revenue Next Year
- SSY N/A
- TCBP N/A
- P/E Ratio
- SSY N/A
- TCBP N/A
- Revenue Growth
- SSY N/A
- TCBP N/A
- 52 Week Low
- SSY $0.53
- TCBP $0.37
- 52 Week High
- SSY $1.91
- TCBP $32.70
- Technical
- Relative Strength Index (RSI)
- SSY 46.48
- TCBP 30.77
- Support Level
- SSY $0.89
- TCBP $0.37
- Resistance Level
- SSY $0.92
- TCBP $0.47
- Average True Range (ATR)
- SSY 0.15
- TCBP 0.10
- MACD
- SSY -0.02
- TCBP 0.01
- Stochastic Oscillator
- SSY 6.76
- TCBP 2.65
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.